|52.42|| +0.30 / +0.58%|
DENTSPLY International, Inc. engages in the manufacturing and distributing of dental and other healthcare products. It designs, develops, manufactures and markets a full range of professional dental products, including dental implants, endodontic instruments and materials, orthodontic appliances, restorative materials, preventive materials and devices and prosthetic materials and devices. The company operates through four segments: Dental Consumable, Dental Laboratory, Dental Specialty and Consumable Medical Device. The Dental Consumable segment consists of dental sundries and small equipment used in dental offices. The Dental Sundries product includes dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners and topical fluoride. The Small equipment product includes high and low speed handpieces, intraoral curing light systems, dental diagnostic systems and ultrasonic scalers and polishers. The Dental laboratory segment consists of dental prosthetics, artificial teeth, precious metal dental alloys, dental ceramics and crown and bridge materials, which are used in the preparation of dental appliances. The Dental Specialty segment consists of endodontic instruments and materials, implants and related products, bone grafting materials, 3D digital implantology, dental lasers and orthodontic appliances and accessories. The Consumable Medical Device segment consists of urological products, including catheters, certain surgical products, medical drills and other non-medical products. It markets its products through distributors, dealers and importers, dentists, dental hygienists, dental assistants, dental laboratories, and dental schools. DENTSPLY International was founded by Jacob F. Frantz, Dean C. Osborne, George H. Whiteley and John R. Sheppard on June 23, 1899 and is headquartered in York, PA.
|Bret W. Wise||Chairman & Chief Executive Officer|
|Christopher T. Clark||President & Chief Financial Officer|
|James G. Mosch||Chief Operating Officer & Executive Vice President|
|Teresa A. Dolan||Chief Clinical Officer & Vice President|
|Andrew M. Lichkus||Chief Technology Officer & Vice President|